ICD-10-CM Billable Code

C50.211

Malignant neoplasm of upper-inner quadrant of right female breast

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code C50.211 refers to a malignant (cancerous) tumor located in the upper-inner part of the right breast in females. This specific diagnosis helps healthcare professionals classify and treat breast cancer based on the exact location within the breast. Breast cancer in this area can vary in size and stage, influencing treatment options and prognosis. Early detection and accurate diagnosis are critical for effective management of the condition.

Causes & Symptoms

Clinical Causes: Genetic mutations and family history of breast cancer Hormonal factors, such as prolonged estrogen exposure Lifestyle factors including alcohol use, obesity, and smoking Radiation exposure to the chest area Age, with higher risk in older women Personal history of breast or other cancers Hormone replacement therapy during menopause

Key Symptoms: Lump in the upper-inner part of the breast Changes in the size, shape, or appearance of the breast Skin changes over the affected area, such as redness or puckering Persistent pain or tenderness in the region Nipple discharge or changes in nipple appearance Swelling or a noticeable thickening of breast tissue Unexplained weight loss or fatigue in advanced cases

Diagnostic & Treatment

Diagnosis Path: Clinical Breast Examination - assessment by a healthcare provider Imaging Tests - mammography and ultrasound to visualize the tumor Biopsy - tissue sampling for histopathological examination to confirm malignancy Additional imaging, such as MRI, may be used for further evaluation Laboratory tests to assess overall health and spread of cancer (staging)

Treatment Protocols: Surgical Removal - lumpectomy or mastectomy to excise the tumor Radiation Therapy - to destroy residual cancer cells after surgery Chemotherapy - systemic treatment to target cancer cells throughout the body Hormone Therapy - for hormone receptor-positive tumors Targeted Therapy - medications aimed at specific genetic markers of the cancer Immunotherapy - in select cases where it is appropriate

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C50.211 a billable ICD-10 code?
Yes, C50.211 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C50.211?
Clinical documentation must specify the nature of Malignant neoplasm of upper-inner quadrant of right female breast and any associated comorbidities for accurate reporting.

Cite this Clinical Reference